UnitedHealth Group Inc. (NYSE:UNH)‘s stock had its “buy” rating reaffirmed by equities research analysts at Jefferies Group in a report issued on Sunday. They presently have a $163.00 price objective on the healthcare conglomerate’s stock. Jefferies Group’s price objective indicates a potential upside of 13.68% from the company’s previous close.

The analysts wrote, “Analysts Have Conflicting Sentiments on These Healthcare Companies: UnitedHealth (NYSE: UNH) and Bristol Myers (NYSE: BMY) | Analyst Ratings

window._wpemojiSettings = {“baseUrl”:”https:\/\/s.w.org\/images\/core\/emoji\/72×72\/”,”ext”:”.png”,”source”:{“concatemoji”:”http:\/\/www.analystratings.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.5.4″}};
!function(a,b,c){function d(a){var c,d,e,f=b.createElement(“canvas”),g=f.getContext&&f.getContext(“2d”),h=String.fromCharCode;if(!g||!g.fillText)return!1;switch(g.textBaseline=”top”,g.font=”600 32px Arial”,a){case”flag”:return g.fillText(h(55356,56806,55356,56826),0,0),f.toDataURL().length>3e3;case”diversity”:return g.fillText(h(55356,57221),0,0),c=g.getImageData(16,16,1,1).data,d=c[0]+”,”+c[1]+”,”+c[2]+”,”+c[3],g.fillText(h(55356,57221,55356,57343),0,0),c=g.getImageData(16,16,1,1).data,e=c[0]+”,”+c[1]+”,”+c[2]+”,”+c[3],d!==e;case”simple”:return g.fillText(h(55357,56835),0,0),0!==g.getImageData(16,16,1,1).data[0];case”unicode8″:return g.fillText(h(55356,57135),0,0),0!==g.getImageData(16,16,1,1).data[0]}return!1}function e(a){var c=b.createElement(“script”);c.src=a,c.type=”text/javascript”,b.getElementsByTagName(“head”)[0].appendChild(c)}var f,g,h,i;for(i=Array(“simple”,”flag”,”unicode8″,”diversity”),c.supports={everything:!0,everythingExceptFlag:!0},h=0;h

var sampling_active = 0;
var sampling_rate = 100;
var do_request = false;

if ( !sampling_active ) {
do_request = true;
} else {
var num = Math.floor(Math.random() * sampling_rate) + 1;
do_request = ( 1 === num );
}

if ( do_request ) {

/* Create XMLHttpRequest object and set variables */
var xhr = ( window.XMLHttpRequest )
? new XMLHttpRequest()
: new ActiveXObject( “Microsoft.XMLHTTP” ),
url = ‘https://www.analystratings.com/wp-admin/admin-ajax.php’,
params = ‘action=update_views_ajax&token=f86784c8d5&wpp_id=456650’;
/* Set request method and target URL */
xhr.open( “POST”, url, true );
/* Set request header */
xhr.setRequestHeader( “Content-type”, “application/x-www-form-urlencoded” );
/* Hook into onreadystatechange */
xhr.onreadystatechange = function() {
if ( 4 === xhr.readyState && 200 === xhr.status ) {
if ( window.console && window.console.log ) {
window.console.log( xhr.responseText );
}
}
};
/* Send request */
xhr.send( params );

}

(function(i,s,o,g,r,a,m){i[‘GoogleAnalyticsObject’]=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,’script’,’//www.google-analytics.com/analytics.js’,’ga’);
ga(‘create’, ‘UA-55014446-1’, ‘auto’);
ga(‘send’, ‘pageview’);

window.$ = jQuery;

–>

Stock Market
Best Performing Analysts
Sectors

Basic Materials
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities

Most Popular
Contact Us

Home » Analysts Have Conflicting Sentiments on These Healthcare Companies: UnitedHealth (NYSE: UNH) and Bristol Myers (NYSE: BMY)”

UNH has been the subject of a number of other research reports. Evercore ISI started coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They set a “buy” rating and a $155.00 price target for the company. Vetr raised UnitedHealth Group from a “buy” rating to a “buy” rating in a research report on Friday, October 7th. Cowen and Company set a $150.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, September 6th. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $161.00 price objective (up previously from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Finally, Leerink Swann reissued an “outperform” rating and issued a $165.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Two research analysts have rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $155.28.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group (NYSE:UNH) opened at 143.39 on Friday. The company’s 50 day moving average price is $137.12 and its 200 day moving average price is $136.75. UnitedHealth Group has a 52-week low of $107.51 and a 52-week high of $144.48. The stock has a market cap of $136.56 billion, a PE ratio of 22.44 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm had revenue of $46.30 billion for the quarter, compared to the consensus estimate of $46.09 billion. During the same period in the previous year, the business earned $1.77 EPS. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group will post $7.90 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.74%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.

In related news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.65% of the stock is currently owned by corporate insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Emerald Acquisition Ltd. purchased a new stake in UnitedHealth Group during the second quarter valued at $309,266,000. Bank of Montreal Can purchased a new stake in UnitedHealth Group during the second quarter valued at $207,013,000. Dodge & Cox boosted its stake in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares in the last quarter. Boston Partners boosted its stake in UnitedHealth Group by 47.6% in the second quarter. Boston Partners now owns 3,531,669 shares of the healthcare conglomerate’s stock valued at $498,672,000 after buying an additional 1,138,808 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in UnitedHealth Group by 2.0% in the second quarter. Vanguard Group Inc. now owns 57,213,923 shares of the healthcare conglomerate’s stock valued at $8,078,605,000 after buying an additional 1,123,084 shares in the last quarter. Institutional investors and hedge funds own 85.80% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.